TK006

BIOLOGICAL3 trials

Sponsors

Jiangsu T-Mab Biopharma Co.,Ltd

Conditions

Breast CancerOsteoporosis

Phase 1

Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases

Jiangsu T-Mab Biopharma Co.,LtdBreast Cancer

Start: 2017-07-20End: 2018-08-31Target: 40Updated: 2017-08-23

Assessment of Anti-RANKL Antibody in Post-menopausal Women

Jiangsu T-Mab Biopharma Co.,LtdOsteoporosis

Start: 2017-08-07End: 2018-12-30Target: 24Updated: 2018-03-14

Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases

Jiangsu T-Mab Biopharma Co.,LtdBreast Cancer

Start: 2018-05-31End: 2019-05-31Target: 30Updated: 2018-04-03